Hope G. Alcorn - Concepedia

Author

Hope G. Alcorn

Also Known As

H G Alcorn, Hope Alcorn, Hope G. Alcorn

Publications

576

Citations

H-Index

Concepts

All Affiliations

Hope G. Alcorn is an author at University of Pittsburgh specializing in medicine, atherosclerosis, and cardiovascular disease.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	99
2	Public Health	2	2	75
3	Epidemiology	2	2	75
4	Health Policy	1	1	45
5	Pharmacology	1	1	24

Hope G. Alcorn

Publications

576

Citations

H-Index

Page 1

	Year	Citations
Risk Factors for Abdominal Aortic Aneurysms in Older Adults Enrolled in the Cardiovascular Health Study Hope G. Alcorn, Sidney K. Wolfson, Kim Sutton‐Tyrrell, Arteriosclerosis Thrombosis and Vascular Biology	1996	343
Predictors of carotid stenosis in older adults with and without isolated systolic hypertension. Kim Sutton‐Tyrrell, Hope G. Alcorn, Sidney K. Wolfson, Stroke	1993	134
Morbidity, Mortality, and Antihypertensive Treatment Effects by Extent of Atherosclerosis in Older Adults With Isolated Systolic Hypertension Kim Sutton‐Tyrrell, Hope G. Alcorn, Holly C. Herzog, Stroke HypertensionSystolic HypertensionBlood PressureAntihypertensive Treatment EffectsStroke	1995	45
Lipoprotein(a) and peripheral atherosclerosis in older adults Kim Sutton-Tyrrell, Elaine N. Meilahn, Hope G. Alcorn Atherosclerosis Metabolic SyndromeCardiovascular DiseaseHyperlipidemiaVascular BiologyDyslipidemia	1996	30
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9 Jame Abraham, André Robidoux, Antoinette R. Tan, Breast Cancer Research and Treatment Breast OncologyOncologyNeoadjuvant Chemotherapy RegimensPharmacologyWeekly Paclitaxel	2015	24

Page 1